Skip to content
News

Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell is an MIT start-up based on breast cancer imaging technology co-developed by Dr. David Kirsch (Radiation Oncology, SOM).